CEimpact Podcast

In this week's of GameChangers Podcast, we delve into the groundbreaking reclassification of marijuana to Schedule III. We discuss  impacts on the legal landscape, medical research, pharmacogenomics for CBD, and the role of healthcare providers.
 
The GameChanger
Marijuana's move to Schedule III will increase research opportunities, ease fear and stigma, and provide healthcare provider involvement in medical benefits and potential risks.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Guest
Marry Vuong, PharmD, BCPPS
Clinical Pharmacy Manager
Perfecting Peds

Reference
UPDATE: DEA Moves to Reschedule Cannabis from Cannabis Business Times

NPR: Scientists welcome new rules on marijuana, but research will still face obstacles.

CEimpact Course for Reference:
Beyond the Haze: Pharmacist's Legal Insights on THC, CBD, and Medical Marijuana

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the reclassification of marijuana from Schedule I to Schedule III.
2. Explain the potential benefits of the marijuana schedule change including its impact on medical research and patient access.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-180-H01-P
Initial release date: 05/27/2024
Expiration date: 05/27/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Join us as we discuss new guidelines from the American College of Gastroenterology for the management of acute pancreatitis.
The GameChanger
New guidelines from the ACG address changes in treatment and management of acute pancreatitis.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
The American Journal of Gastroenterology
Drug-Induced Acute Pancreatitis: An Evidence-Based Classification

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss changes Review the American College of Gastroenterology guidelines for the management of acute pancreatitis. 
2. Discuss changes in treatment of acute pancreatitis.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-175-H01-P
Initial release date: 05/20/2024
Expiration date: 05/20/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Traumatic patient interactions may not occur very often, depending on where you practice, but they are important teaching opportunities on many levels. It’s not just how you navigate trauma with a pharmacy learner that matters, but how you support them in processing what has occurred.

In this episode, we bring together a preceptor and her former resident for an impactful conversation on how to best assess, navigate, and process traumatic patient interactions with pharmacy residents or student pharmacists, and how those learnings transfer to other areas of pharmacy practice after the fact.

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guests
Samantha Katzman, PharmD, BCEMP
Clinical Pharmacy Specialist – Emergency Medicine
University of Louisville Health – Jewish Hospital
Louisville, KY

McKenzie Packard, PharmD, BCPPS
Pediatric Clinical Pharmacist
Atrium Health Wake Forest Baptist
Winston-Salem, NC

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:
1. Discuss strategies to assess pharmacy resident or student pharmacist readiness for a potentially traumatic patient interaction
2. Describe strategies preceptors can use to support pharmacy learners after a traumatic patient interaction

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-177-H99-P
Initial release date: 5/15/2024
Expiration date: 5/15/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Want more information on this and related topics?

Follow CEimpact on Social Media:
LinkedIn
Instagram

Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.
 
The GameChanger
Significantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
New England Journal of Medicine Article

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

New guidelines suggest that for most asthma patients a single inhaler strategy with both an ICS and a quick onset LABA can be used for maintenance and rescue therapy. This has been shown to improve symptoms and decrease need for health care visits. But what is the latest data on SMART therapy and what are the barriers to its use?

The GameChanger: SMART therapy should be the standard of care for most asthma patients.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Meta-analysis
https://pubmed.ncbi.nlm.nih.gov/35230437/

Asthma Action Plan
Do You Have an Asthma Action Plan?

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the latest information concerning SMART therapy in asthma.
2. Discuss how healthcare workers can decrease barriers and increase acces to SMART therapy.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-165-H01-P
Initial release date: 05/06/2024
Expiration date: 05/06/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

In this episode, we tackle a whole range of issues – how to assess and meet our pharmacy residents and student pharmacists where they are, the challenges of maintaining guardrails while providing flexibility, and the responsibility we have as preceptors to stay abreast of best practices not only clinically, but as teachers and mentors so that we can make changes to our precepting practice when they are needed.

Guest, Kelly Erdos is the Residency Program Director at Banner Baywood Medical Center in Mesa, AZ. She shares several great examples of how small adjustments in our precepting practice can have a big impact on our learners and ourselves. Tune in to hear more!

Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Kelly Erdos, PharmD, BCACP, CACP
Pharmacy Clinical Coordinator Supervisor
Residency Program Director
Banner Baywood Medical Center, Mesa, AZ

Get CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:

1. Describe the importance of adapting precepting strategies to meet pharmacy residents and student pharmacists where they are in their development 
2. Identify strategies to assess pharmacy resident or student pharmacist readiness for a given rotation experience

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-171-H99-P
Initial release date: 05/01/2024
Expiration date: 05/01/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.
ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this P2P episode.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

40% of people experience vertigo in their lifetime. These simple questions help us know what's causing it and how to provide relief to patients through medications or triaging to the appropriate provider.
 
The GameChanger
Migraine headaches can present as vertigo. Simple questions and recommendations from pharmacists can be lifechanging for these patients.
 
Guest
Sarah Powell, MD
Physician, Surgeon
Ear, Nose, and Throat Consultants

 
Reference
https://entad.org/resources/patient-information-dr-teixido/migraine-management-for-otolaryngologists/

Migraine Handout
Migraine, More Than A Headache


Pharmacist Members,REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. List three ways patients present with symptoms of vertigo.
2. Describe how to manage patient symptoms with medications or triage to another healthcare provider.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-158-H01-P
Initial release date: 04/29/2024
Expiration date: 04/29/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Join us this episode as we discuss new recommendations from the American Dental Association on acute pain management.
 
The GameChanger
Dosing acetaminophen and ibuprofen where they peak at the same time due to their synergistic properties, resulting in treatment being often more effective than hydrocodone-apap and oxycodone-apap for pain relief.
 
Guest
Karen Baker, M.S.Pharm., R.Ph
Associate Professor
Colleges of Dentistry and Pharmacy, University of Iowa


Reference
https://www.ada.org/about/press-releases/new-guideline-details-acute-pain-management-strategies-for-adolescent-adult-dental-patients

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss new guideline details on acute pain management for dental patients.
2. Identify how appropriate prescribing for acute dental pain can improve treatment and outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-157-H01-P
Initial release date: 04/22/2024
Expiration date: X/042/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Shortages, access, and cost have led to compounding GLP1s, which has created confusion and misinformation for patients and healthcare providers. Join us as we discuss this practice and delve into what you need to know as a healthcare provider.

THE GAMECHANGER: The advent of GLP1s is a true GameChanger in the health of patients with diabetes, cardiovascular diseases, and obesity, and has led to access issues for manufactured products.

 

Guests
Tenille Davis, PharmD, RPh
Chief Advocacy Officer
Alliance for Pharmacy Compounding

Scott Brunner, CAE
CEO
Alliance for Pharmacy Compounding

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
https://a4pc.org/advocacy/educating-prescribers/

https://a4pc.org/advocacy/statements-and-other-resources/

https://a4pc.org/files/APC-Compounded-GLP-1s-Media-Brief-REVISED-March-2024.pdf

 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Review criteria for compounding drugs on the FDA drug shortage list.
2. Discuss the facts and misinformation surrounding compounded GLP1 medications.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-145-H01-P
Initial release date: 04/15/2024
Expiration date: 04/15/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B.
 
The GameChanger
HHS updates the Inflation Reduction Act that will impact over 750, 000 people.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Reduced Coinsurance for Certain Part B Rebatable Drugs Under the Medicare Prescription Drug  Inflation Rebate Program
 

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the monetary impact of the Inflation Reduction Act.
2. Discuss how the Medicare Part B drug addition will benefit patients.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-136-H04-P
Initial release date: 4/08/2024
Expiration date: 04/08/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram